Cc1ccc2c(c1)C1C[N+](C)(CC(=O)Nc3ccccc3Cl)CCC1N2C(=O)c1ccccc1Cl.[Cl-]
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?